search
Back to results

Effects of Black Soy Peptide Supplementation on Blood Pressure

Primary Purpose

Hypertension

Status
Completed
Phase
Phase 3
Locations
Korea, Republic of
Study Type
Interventional
Intervention
black soy peptide
Sponsored by
Yonsei University
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional basic science trial for Hypertension

Eligibility Criteria

30 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Average systolic blood pressure (SBP) between 130 to 159 mmHg
  • Average diastolic blood pressure (DBP) between 80 to 99 mmHg, or both, based on an average of six measurements during two screening visits

Exclusion Criteria:

  • Previous diagnosed clinical hypertension
  • Self-reported use of anti-hypertensive medication
  • Abnormal liver or renal function
  • History of cardiovascular disease, cancer, thyroid or pituitary disease, or any other serious life-threatening illness that required regular medical treatment

Sites / Locations

  • Laboratory of Clinical Nutrigenetics/Nutrigenomic

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

4.5g/day black soy peptide

placebo

Arm Description

4.5 g/day, 8weeks

similar appearance to the black soy peptide tablet, 8 weeks

Outcomes

Primary Outcome Measures

change from baseline in Systolic blood pressure at 8 weeks

Secondary Outcome Measures

Change from baseline in Diastolic blood pressure at 8 weeks
change from baseline in plasma malondialdehyde at 8 weeks
change from baseline in Urinary 8-epi-prostaglandin F2 at 8 weeks
change from baseline in Renin at 8 weeks
Change from baseline in angiotensin-converting enzyme at 8 weeks

Full Information

First Posted
August 10, 2012
Last Updated
August 27, 2012
Sponsor
Yonsei University
search

1. Study Identification

Unique Protocol Identification Number
NCT01674491
Brief Title
Effects of Black Soy Peptide Supplementation on Blood Pressure
Official Title
Effects of Black Soy Peptide Supplementation on Blood Pressure and Oxidative Stress:A Randomized Controlled Trial
Study Type
Interventional

2. Study Status

Record Verification Date
August 2012
Overall Recruitment Status
Completed
Study Start Date
July 2011 (undefined)
Primary Completion Date
September 2011 (Actual)
Study Completion Date
March 2012 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Yonsei University

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Black soy peptides have been shown to possess properties that may decrease blood pressure. To examine the effects of black soy peptides supplementation on blood pressure and oxidative stress in subjects with pre-hypertension or stage I hypertension.
Detailed Description
Trial participants included men and women aged 30 to 65 years who had an average systolic blood pressure (SBP) between 130 to 159 mmHg, average diastolic blood pressure (DBP) between 80 to 99 mmHg, or both, based on an average of six measurements during two screening visits. Participants were supplied with 84 pouches of placebo (casein) or black soy peptide (3 pouches/day) at 0-week and at 4-week visits. Test group subjects received pouches containing black soy peptides (4.5 g/day total soy peptides for 8 weeks). The control group received pouches containing casein that had a similar appearance to the black soy peptide tablet. During the intervention, we instructed study participants to continue their current food intake patterns and lifestyles so that total energy intake and energy expenditure would be constant during the course of trial. Participants brought back unconsumed pouches at their 4- and 8-week follow-up visits. The dietitian counted the number of returned pouches, and we used this to assess the participants' adherence to their assigned intervention.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension

7. Study Design

Primary Purpose
Basic Science
Study Phase
Phase 3
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
100 (Actual)

8. Arms, Groups, and Interventions

Arm Title
4.5g/day black soy peptide
Arm Type
Experimental
Arm Description
4.5 g/day, 8weeks
Arm Title
placebo
Arm Type
Placebo Comparator
Arm Description
similar appearance to the black soy peptide tablet, 8 weeks
Intervention Type
Dietary Supplement
Intervention Name(s)
black soy peptide
Intervention Description
black soy peptide: 4.5g/day for 8 weeks
Primary Outcome Measure Information:
Title
change from baseline in Systolic blood pressure at 8 weeks
Time Frame
8 weeks
Secondary Outcome Measure Information:
Title
Change from baseline in Diastolic blood pressure at 8 weeks
Time Frame
8 weeks
Title
change from baseline in plasma malondialdehyde at 8 weeks
Time Frame
8 weeks
Title
change from baseline in Urinary 8-epi-prostaglandin F2 at 8 weeks
Time Frame
8 weeks
Title
change from baseline in Renin at 8 weeks
Time Frame
8 weeks
Title
Change from baseline in angiotensin-converting enzyme at 8 weeks
Time Frame
8 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
30 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Average systolic blood pressure (SBP) between 130 to 159 mmHg Average diastolic blood pressure (DBP) between 80 to 99 mmHg, or both, based on an average of six measurements during two screening visits Exclusion Criteria: Previous diagnosed clinical hypertension Self-reported use of anti-hypertensive medication Abnormal liver or renal function History of cardiovascular disease, cancer, thyroid or pituitary disease, or any other serious life-threatening illness that required regular medical treatment
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Jong Ho Lee, Ph.D
Organizational Affiliation
Yonsei University
Official's Role
Principal Investigator
Facility Information:
Facility Name
Laboratory of Clinical Nutrigenetics/Nutrigenomic
City
Seoul
ZIP/Postal Code
120-749
Country
Korea, Republic of

12. IPD Sharing Statement

Learn more about this trial

Effects of Black Soy Peptide Supplementation on Blood Pressure

We'll reach out to this number within 24 hrs